A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain

C-X-C chemokine receptor type 4 (CXCR4) is a receptor for a pleiotropic chemokine CXCL12. Previous studies have shown that the acute administration of the CXCR4 antagonist AMD3100 reduced neuroinflammation in stroke brain and mobilized bone marrow hematopoietic stem cells (HSCs). The purpose of this...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cell Transplant
Hoofdauteurs: Wu, Kuo-Jen, Yu, Seong-Jin, Shia, Kak-Shan, Wu, Chien-Huang, Song, Jen-Shin, Kuan, Hsuan-Hao, Yeh, Kai-Chia, Chen, Chiung-Tong, Bae, Eunkyune, Wang, Yun
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2017
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5661213/
https://ncbi.nlm.nih.gov/pubmed/27938478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096368916X693563
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items